TD SYNNEX CORP Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Td Synnex Corp quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and growth rate from Q4 2014 to Q4 2023.
  • Td Synnex Corp Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending November 30, 2023 was $1.03B, a 97.7% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.03B +$511M +97.7% Nov 30, 2023 10-K 2024-01-26
Q3 2023 $1.25B +$900M +256% Aug 31, 2023 10-Q 2023-10-03
Q2 2023 $852M +$330M +63.3% May 31, 2023 10-Q 2023-07-06
Q1 2023 $539M +$28.9M +5.66% Feb 28, 2023 10-Q 2023-04-05
Q4 2022 $523M -$472M -47.4% Nov 30, 2022 10-K 2024-01-26
Q3 2022 $351M -$3.7B -91.3% Aug 31, 2022 10-Q 2023-10-03
Q2 2022 $522M -$1.14B -68.5% May 31, 2022 10-Q 2023-07-06
Q1 2022 $510M -$934M -64.7% Feb 28, 2022 10-Q 2023-04-05
Q4 2021 $995M -$574M -36.6% Nov 30, 2021 10-Q 2023-10-03
Q3 2021 $4.05B +$2.59B +178% Aug 31, 2021 10-Q 2022-10-04
Q2 2021 $1.66B +$540M +48.4% May 31, 2021 10-Q 2022-07-07
Q1 2021 $1.44B +$1.14B +379% Feb 28, 2021 10-Q 2021-04-08
Q4 2020 $1.57B +$1.42B +963% Nov 30, 2020 10-Q 2022-10-04
Q3 2020 $1.46B +$1.19B +445% Aug 31, 2020 10-Q 2020-10-09
Q2 2020 $1.12B +$841M +304% May 31, 2020 10-Q 2020-07-09
Q1 2020 $301M +$51.7M +20.7% Feb 29, 2020 10-Q 2020-04-07
Q4 2019 $148M -$314M -68% Nov 30, 2019 8-K 2021-09-01
Q3 2019 $267M +$56.3M +26.7% Aug 31, 2019 10-Q 2020-10-09
Q2 2019 $277M -$84M -23.3% May 31, 2019 10-Q 2020-07-09
Q1 2019 $250M -$129M -34% Feb 28, 2019 10-Q 2020-04-07
Q4 2018 $462M -$94.7M -17% Nov 30, 2018 10-K 2021-01-28
Q3 2018 $211M -$36.2M -14.6% Aug 31, 2018 10-Q 2019-10-04
Q2 2018 $361M +$50.6M +16.3% May 31, 2018 10-Q 2019-07-03
Q1 2018 $378M +$165M +77% Feb 28, 2018 10-Q 2019-04-09
Q4 2017 $557M +$170M +43.8% Nov 30, 2017 10-K 2021-01-28
Q3 2017 $247M +$20.6M +9.09% Aug 31, 2017 10-Q 2018-10-09
Q2 2017 $310M -$281M -47.6% May 31, 2017 10-Q 2018-07-06
Q1 2017 $214M Feb 28, 2017 10-Q 2018-04-06
Q4 2016 $387M -$37.5M -8.82% Nov 30, 2016 10-K 2020-01-29
Q3 2016 $227M Aug 31, 2016 10-Q 2017-10-03
Q2 2016 $591M May 31, 2016 10-Q 2017-07-06
Q4 2015 $425M +$210M +98% Nov 30, 2015 10-K 2019-01-28
Q4 2014 $214M Nov 30, 2014 10-K 2018-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.